2011•Clinical Colorectal CancerRequires access

Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group

Alexander Baraniskin, Johanna B. Munding, Karsten Schulmann, Dominik Meier, Rainer Porschen, Hendrik‐Tobias Arkenau, Ullrich Graeven, Wolff Schmiegel, Andrea Tannapfel, Anke Reinacher‐Schick

Open publisher page 16 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Oxaliplatin, Medicine, Colorectal cancer, Capecitabine, Internal medicine, Oncology, Chemotherapy, Fluorouracil